Clinical Trial Update: Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing Lactobacillus reuteri DSM 17938 to placebo for infantile colic has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Colic

Drugs mentioned

• Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Colic | Phase 2 | Status: COMPLETED